Cardiovascular comorbidities antedating the diagnosis of rheumatoid arthritis

被引:43
|
作者
Kerola, Anne M. [1 ,2 ,3 ]
Kerola, Tuomas [3 ]
Kauppi, Markku J. [2 ,4 ]
Kautiainen, Hannu [5 ]
Virta, Lauri J. [6 ]
Puolakka, Kari [7 ]
Nieminen, Tuomo V. M. [3 ,4 ,8 ]
机构
[1] Univ Helsinki, Sch Med, FI-00029 Helsinki, Finland
[2] Paijat Hame Cent Hosp, Div Rheumatol, Dept Internal Med, Lahti, Finland
[3] Paijat Hame Cent Hosp, Div Cardiol, Dept Internal Med, Lahti, Finland
[4] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland
[5] Kuopio Univ Hosp, Unit Primary Hlth Care, SF-70210 Kuopio, Finland
[6] Social Insurance Inst, Res Dept, Turku, Finland
[7] South Karelia Cent Hosp, Dept Med, Lappeenranta, Finland
[8] Univ Helsinki, Cent Hosp, Div Cardiol, FI-00029 Helsinki, Finland
关键词
Rheumatoid Arthritis; Cardiovascular Disease; Rheumatoid Factor; Epidemiology; POPULATION-BASED COHORT; CORONARY-HEART-DISEASE; RISK-FACTORS; MYOCARDIAL-INFARCTION; PROGNOSTIC-FACTORS; ONSET; MORTALITY; AGE; POLYMORPHISM; FINLAND;
D O I
10.1136/annrheumdis-2012-202398
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To assess the prevalence of coronary heart disease (CHD) and chronic hypertension among patients with rheumatoid arthritis (RA) at the time of diagnosis, in comparison with age-specific and sex-specific non-RA subjects. Furthermore, the impacts of age at the onset of RA, as well as gender and the presence of rheumatoid factor (RF) on the risk of these comorbidities, were evaluated. Methods A cohort of 7209 RA patients diagnosed between January 2004 and December 2007 was identified, based on a Finnish nationwide register on special reimbursements for medication costs. The presence of CHD and chronic hypertension antedating the diagnosis of RA was identified from the same register. The prevalence of the cardiovascular comorbidities was compared with the general Finnish population, and a standardised rate ratio (SRR) for both these cardiovascular diseases was calculated. Results The risk of having CHD at RA diagnosis was slightly elevated, the SRR being 1.10 (95% CI 1.01 to 1.20). Younger age at the onset of RA seemed to be related with higher SRR for CHD. In a subset analysis, an increased prevalence of hypertension (SRR 1.19, 95% CI 1.10 to 1.30) and CHD (SRR 1.15, 95% CI 1.00 to 1.32) was apparent only among the RF negative RA cases. Conclusions The SRR for CHD is augmented in RA patients already at disease onset, and more pronouncedly in early onset RA. The findings highlight the importance of early prevention of atherosclerosis, regardless of RF status.
引用
收藏
页码:1826 / 1829
页数:4
相关论文
共 50 条
  • [21] Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis
    Nas, Kemal
    Karkucak, Murat
    Durmus, Bekir
    Karatay, Saliha
    Capkin, Erhan
    Kaya, Arzu
    Ucmak, Derya
    Akar, Zeynel Abidin
    Cevik, Remzi
    Kilic, Erkan
    Kilic, Gamze
    Ozgocmen, Salih
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2015, 18 (08) : 873 - 879
  • [22] Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the Implementation of Cardiovascular Risk Management in Rheumatoid Arthritis project
    van den Oever, Inge A. M.
    Heslinga, Maaike
    Griep, Ed N.
    Griep-Wentink, Hanneke R. M.
    Schotsman, Rob
    Cambach, Walter
    Dijkmans, Ben A. C.
    Smulders, Yvo M.
    Lems, Willem F.
    Boers, Maarten
    Voskuyl, Alexandre E.
    Peters, Mike J. L.
    van Schaardenburg, Dirkjan
    Nurmohamed, Micheal T.
    RHEUMATOLOGY, 2017, 56 (09) : 1472 - 1478
  • [23] Cardiovascular Effects of Methotrexate in Rheumatoid Arthritis Revisited
    Popkova, Tatyana V.
    Novikova, Diana S.
    Gasparyan, Armen Yuri
    Nasonov, Evgeny L.
    CURRENT MEDICINAL CHEMISTRY, 2015, 22 (16) : 1903 - 1910
  • [24] Cardiovascular disease in rheumatoid arthritis: a step forward
    Myasoedova, Elena
    Gabriel, Sherine E.
    CURRENT OPINION IN RHEUMATOLOGY, 2010, 22 (03) : 342 - 347
  • [25] Hydroxychloroquine and Cardiovascular Events in Patients with Rheumatoid Arthritis
    Sanchez, Andres Cordova
    Khokhar, Farzam
    Olonoff, Danielle A.
    Carhart, Robert L.
    CARDIOVASCULAR DRUGS AND THERAPY, 2024, 38 (02) : 297 - 304
  • [26] Rheumatoid arthritis - cardiovascular risk is high, but manageable
    Fiehn, C.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (05) : 202 - 204
  • [27] Association of physical inactivity with increased cardiovascular risk in patients with rheumatoid arthritis
    Metsios, Giorgos S.
    Stavropoulos-Kalinoglou, Antonios
    Panoulas, Vasileios F.
    Wilson, Mat
    Nevill, Alan M.
    Koutedakis, Yiannis
    Kitas, George D.
    EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2009, 16 (02): : 188 - 194
  • [28] Treating Cardiovascular Disease in the Inflammatory Setting of Rheumatoid Arthritis: An Ongoing Challenge
    Godbole, Saloni
    Solomon, Jenny Lue
    Johnson, Maryann
    Srivastava, Ankita
    Carsons, Steven E.
    Belilos, Elise
    De Leon, Joshua
    Reiss, Allison B.
    BIOMEDICINES, 2024, 12 (07)
  • [29] Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
    Kerola, Anne Mirjam
    Rollefstad, Silvia
    Semb, Anne Grete
    EUROPEAN CARDIOLOGY REVIEW, 2021, 16
  • [30] Cardiovascular Complications of Rheumatoid Arthritis: Prevalence and Pathogenesis
    Krougly, L. B.
    Fomicheva, O. A.
    Karpov, Yu. A.
    Popkova, T. V.
    Novikova, D. S.
    Nasonov, E. L.
    KARDIOLOGIYA, 2016, 56 (06) : 89 - 95